Zobrazeno 1 - 10 of 11 pro vyhledávání: '"Hopethe Hubbard"'
1
Akademický článek
Cholangiolytic Changes in Statin-Induced Liver Injury
Autor: Preethi Dileep Menon, Tamneet Singh, Hopethe Hubbard, Sarah Hackman, Francis E. Sharkey
Publikováno v: Case Reports in Pathology, Vol 2020 (2020)
Atorvastatin is a commonly used oral cholesterol-lowering agent. Side effects associated with statin therapy include arthralgia, myalgia, dyspepsia, weakness, and headache. Prospective and retrospective studies of drug-induced liver injury have ident
Externí odkaz: https://doaj.org/article/ea124d38792b4e188d7d68c67d623654
Zobrazit plný text záznamu
2
Cholangiolytic Changes in Statin-Induced Liver Injury
Autor: Sarah Hackman, Francis E. Sharkey, Tamneet Singh, Preethi Dileep Menon, Hopethe Hubbard
Publikováno v: Case Reports in Pathology, Vol 2020 (2020)
Case Reports in Pathology
Atorvastatin is a commonly used oral cholesterol-lowering agent. Side effects associated with statin therapy include arthralgia, myalgia, dyspepsia, weakness, and headache. Prospective and retrospective studies of drug-induced liver injury have ident
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eb26096db3ea9d5b50bee2e669f1eb6
https://doaj.org/article/ea124d38792b4e188d7d68c67d623654
Zobrazit plný text záznamu
3
Pantoprazole-induced acute hepatocellular and cholestatic hepatitis
Autor: Hopethe Hubbard, Eugene Stolow, Archish Kataria
Publikováno v: Postgraduate Medical Journal. 98:11-12
Pantoprazole is a proton pump inhibitor (PPI) widely used to manage acid-related disorders. It is well tolerated with an excellent safety profile.1 Mild, transient asymptomatic elevations in serum aminotransferases is common with pantoprazole use. Th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01d090c0fdc5e74087e538b92e78b8b0
https://doi.org/10.1136/postgradmedj-2020-138838
Zobrazit plný text záznamu
9
Next-Generation Regimens
Autor: John Vizuete, Hopethe Hubbard, Eric Lawitz
Publikováno v: Clinics in Liver Disease. 19:707-716
The treatment of chronic hepatitis C virus (HCV) has undergone a period of rapid evolution. The era of combination direct antivirals has led to high rates of sustained viral response (SVR), limited toxicities, and more broad applicability across pati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::31c750badff16529b5ccceb420cc9143
https://doi.org/10.1016/j.cld.2015.06.009
Zobrazit plný text záznamu
10
Real World Experience in the Era of First Generation Protease Inhibitors in the Treatment of Hepatitis C
Autor: Hopethe Hubbard, Eric Lawitz
Publikováno v: Current Hepatitis Reports. 12:189-194
The treatment for hepatitis C has been revolutionized with the new era of protease inhibitors. Boceprevir (BOC) and telaprevir (TVR) are potent first generation direct acting antivirals which have demonstrated significantly improved response rates co
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::064fb5d85c6c6e2e9bfd621bf1a52004
https://doi.org/10.1007/s11901-013-0189-z
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje